Aptevo Therapeutics Inc. (APVO)
NASDAQ · Healthcare
Aptevo Therapeutics Inc. Operating Income 2015–2022
Aptevo Therapeutics Inc. annual/quarterly operating income history and growth rate from 2015 to 2022. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Aptevo Therapeutics Inc. operating income for the quarter ending March 31, 2022 was -5.6 M, a 18.54% decrease year-over-year.
- Aptevo Therapeutics Inc. operating income for the twelve months ending March 31, 2022 was -23.0 M, a 38.59% decrease year-over-year.
- Aptevo Therapeutics Inc. annual operating income for 2022 was -28.6 M, a 33.84% increase from 2021.
- Aptevo Therapeutics Inc. annual operating income for 2021 was -21.4 M, a 22.16% decrease from 2020.
- Aptevo Therapeutics Inc. annual operating income for 2020 was -27.5 M, a 32.88% decrease from 2019.
- Aptevo Therapeutics Inc. annual operating income for 2019 was -41.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aptevo Therapeutics Inc. Operating Income — FAQ
Aptevo Therapeutics Inc. (APVO) operating income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Aptevo Therapeutics Inc.'s operating income?
Aptevo Therapeutics Inc. (APVO) reported operating income of -$29M for fiscal 2022.
Where can I see APVO's operating income history?
The chart and table above show Aptevo Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.